RAB25 and breast cancer: Elevated levels of RAB25 are reported in the ER and PR positive subtypes of breast cancer [14] and in the ER and PR negative breast cancer subtypes; we see the loss of RAB25 leading to activation of the RAS signaling pathway [15, 16].